
Validea's guru fundamental report indicates Microsoft (MSFT) scores 86% on its 'Patient Investor' model, derived from Warren Buffett's strategy, signaling 'some interest' based on strong underlying fundamentals and valuation. The analysis highlights MSFT's predictable profitability, low debt, and robust free cash flow, suggesting the large-cap growth stock aligns with long-term value investment criteria despite failing the 'Initial Rate of Return' test.
Microsoft (MSFT) scores a favorable 86% based on Validea's 'Patient Investor' model, which is derived from Warren Buffett's investment strategy. This score signifies notable interest, as it surpasses the 80% threshold, indicating that the company's fundamentals and valuation are largely aligned with the model's criteria for long-term, predictable enterprises. The analysis reveals MSFT passed eight of nine key tests, demonstrating strength in earnings predictability, debt service capacity, return on equity, and return on total capital. Furthermore, the company shows proficiency in generating free cash flow, effectively using retained earnings, and returning capital to shareholders via repurchases. The single point of failure is the 'Initial Rate of Return' test, which suggests that while MSFT is a high-quality business, its current stock price may not offer the immediate valuation-based upside a strict value investor would demand for a new position.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment